Hybrid inhibitors of phosphatidylinositol 3-kinase (PI3K) and the mammalian target of rapamycin (mTOR): design, synthesis, and superior antitumor activity of novel wortmannin-rapamycin conjugates.

Source:http://linkedlifedata.com/resource/pubmed/id/19928864

J. Med. Chem. 2010 Jan 14 53 1 452-9

Download in:

View as

General Info

PMID
19928864